BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced that Butterfly iQ3™, its third-generation handheld ultrasound device, was the recipient of the Best Medical Technology Award at the 2024 Prix Galien USA Awards by the Galien Foundation..

马萨诸塞州伯灵顿（BURLINGTON）和纽约（BUSINESS WIRE）--Butterfly Network，Inc.（“Butterfly”）（纽约证券交易所：BFLY）是一家数字健康公司，通过便携式、基于半导体的超声波技术和直观软件的力量来改变护理，今天宣布，其第三代手持式超声波设备Butterfly iQ3™在2024年加利恩美国大奖赛上获得了加利恩基金会颁发的最佳医疗技术奖。。

The Galien Foundation was established to foster and reward outstanding achievements in improving the global human condition through the development of innovative drugs and other treatments. First created in 1970 in honor of Galien, the father of medical science and modern pharmacology, the Prix Galien Awards have since grown into an influential program convening healthcare stakeholders across industry, science, government and medical press worldwide.

加利安基金会的成立是为了通过开发创新药物和其他治疗方法来促进和奖励在改善全球人类状况方面取得的杰出成就。加利恩奖（Prix Galien Awards）于1970年首次设立，以纪念医学科学和现代药理学之父加利恩（Galien），自此，加利恩奖已发展成为一项有影响力的计划，吸引了全球行业、科学、政府和医学新闻界的医疗保健利益相关者。

The Prix Galien Awards are regarded as the “Nobel Prize of Life Sciences,” and the highest accolade for healthcare research and development..

加利恩奖（Prix Galien Awards）被认为是“诺贝尔生命科学奖”，也是医疗保健研究与开发的最高荣誉。。

This prestigious recognition highlights Butterfly’s commitment to making ultrasound imaging more affordable, sustainable, and scalable through its pioneering Ultrasound-on-Chip™ technology. The Butterfly iQ3 represents a leap forward in ultrasound technology, building upon the success of its predecessors with enhanced AI-powered features and novel digital image capture capabilities.

这一备受赞誉的奖项突显了Butterfly致力于通过其开创性的片上超声技术，使超声成像更加经济、可持续和可扩展。Butterfly iQ3代表了超声波技术的一次飞跃，它基于其前辈的成功，具有增强的人工智能功能和新颖的数字图像捕获功能。

Built on Butterfly’s proprietary P4.3 semiconductor – its most powerful Ultrasound-on-Chip™ platform released to date – the iQ3 represents a digital revolution in the ultrasound industry by offering clinicians portable, semiconductor-based imaging with premium handheld quality..

。。

“Winning the Prix Galien Award for Best Medical Technology is an extraordinary testament to the hard work and dedication of our team that brought iQ3 to market this year,” said Joseph DeVivo, President, Chief Executive Officer, and Board Chairman of Butterfly Network. “Our Ultrasound-on-Chip™ technology harnesses the exponential advancements of Moore’s Law, allowing us to deliver increasingly powerful and cost-effective imaging tools.

Butterfly Network总裁、首席执行官兼董事会主席约瑟夫·德维沃（JosephDeVivo）表示：“获得加利恩奖最佳医疗技术奖是对我们团队辛勤工作和奉献精神的非凡证明，我们的团队今年将iQ3推向了市场。”我们的超声波芯片™技术利用了摩尔定律的指数级进步，使我们能够提供越来越强大且具有成本效益的成像工具。

By leveraging this innovation, we are democratizing ultrasound, enabling practitioners everywhere to make faster, more accurate decisions, and ultimately transforming patient care on a global scale.”.

通过利用这一创新，我们正在使超声波民主化，使各地的从业者能够做出更快，更准确的决策，并最终在全球范围内改变患者护理。”。

Alongside Butterfly, this year’s awardees across various categories includes Pfizer, AstraZeneca, Daiichi Sankyo US, and other highly respected industry leaders.

除蝴蝶奖外，今年各类奖项的获得者还包括辉瑞（Pfizer）、阿斯利康（AstraZeneca）、美国第一三共（Daiichi Sankyo US）和其他备受尊敬的行业领袖。

In today’s announcement, Michael Rosenblatt, MD, Chair of the Prix Galien USA Awards Committee, Former Dean of Tufts University School of Medicine, and former Chief Medical Officer of Merck & Co. Inc., commented, 'The Awards Committee is honored to witness the exceptional dedication and creativity of our nominees as they turn visionary ideas into transformative solutions for patients worldwide.

在今天的公告中，Prix Galien USA奖项委员会主席、塔夫茨大学医学院前院长、默克公司前首席医疗官、医学博士迈克尔·罗森布拉特（Michael Rosenblatt）评论道：“奖项委员会很荣幸看到我们的提名者在将远见卓识转化为全球患者的变革性解决方案时表现出非凡的奉献精神和创造力。

Their unwavering commitment to advancing patient care is truly commendable, and we are honored to celebrate their outstanding contributions to global health.”.

。

Butterfly is honored to be recognized as the Best Medical Technology against a world-class group of nominees. To view the full list of 2024 nominees, visit: https://www.prnewswire.com/news-releases/the-galien-foundation-announces-2024-prix-galien-usa-nominees-for-best-digital-health-solution-best-medical-technology-incubators-accelerators-and-equity-and-best-startup-302220657.html..

与世界级的提名者相比，蝴蝶队很荣幸被公认为最佳医疗技术。要查看2024名提名者的完整名单，请访问：https://www.prnewswire.com/news-releases/the-galien-foundation-announces-2024-prix-galien-usa-nominees-for-best-digital-health-solution-best-medical-technology-incubators-accelerators-and-equity-and-best-startup-302220657.html..

About the Galien Foundation

关于Galien基金会

The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives..

加利恩基金会鼓励、认可和奖励在科学创新方面的卓越表现，以改善人类健康状况。我们的愿景是成为下一代创新治疗和技术发展的催化剂，这些创新治疗和技术将影响医疗实践和挽救生命。。

The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries and Africa. The Prix Galien was created in 1970 by Roland Mehl in honor of Galien, the father of medical science and modern pharmacology.

该基金会负责监督和指导美国加利恩奖（Prix Galien）的活动，加利恩奖是一个致力于通过创新药物开发取得进展的国际奖项项目，其分会分布在14个国家和非洲。加利恩奖由罗兰·梅尔于1970年创立，以纪念医学和现代药理学之父加利恩。

Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research..

在世界范围内，加利恩奖被认为相当于诺贝尔生物制药研究奖。。

About Butterfly Network

关于Butterfly Network

Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound.

蝴蝶网络（Butterfly Network）由乔纳森·罗斯伯格（Jonathan Rothberg）博士于2011年成立，是一家数字健康公司，其使命是通过提供价格合理、易于使用、全球可访问且智能连接的高质量超声波，使医疗成像民主化，包括为全球47亿无法使用超声波的人提供超声波。

Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law, to launch its second-generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements.

Butterfly利用半导体技术创建了世界上第一个手持式单探头全身超声波系统Butterfly iQ。该公司利用摩尔定律的优势，不断创新，于2020年推出第二代Butterfly iQ+，2024年推出第三代iQ3，每一代都具有更高的处理能力和性能增强。

The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world.

这项颠覆性技术已获得《时代》最佳发明奖、Fast公司改变世界的理念奖、CNBC Disruptor 50奖和MedTech突破奖等荣誉。凭借其专有的超声芯片技术、智能软件和教育产品，Butterfly正在为超声波的大规模应用铺平道路，以便对世界各地的健康状况进行早期检测和远程管理。

Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: www.butterflynetwork.com/choose-your-country..

蝶形装置可在非洲、亚洲、澳大利亚、欧洲、中东、北美和南美部分地区的训练有素的医疗保健从业人员那里买到；要了解有关可用国家的更多信息，请访问：www.butterflynetwork.com/choose your country。。